BioAdvance was awarded a portion of the Commonwealth of Pennsylvania's tobacco settlement monies to grow the life sciences industry in Southeastern Pennsylvania. Fulfilling this mission, BioAdvance: invests in emerging life sciences technologies with the most promising commercialization prospects; accelerates the transfer of technology from research laboratories to start-ups and established companies; builds collaborations between academic, entrepreneurial, corporate, financial, and government partners; and attracts, retains, and supports life sciences entrepreneurs. BioAdvance is now one of the nation's leading investors providing essential pre-seed and seed stage funding to emerging life sciences companies. BioAdvance is currently working with Cira Discovery Sciences to help find buyers and licensees for Cira's intellectual property.